• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VanEck Pharmaceutical ETF (NQ:PPH)

114.41 +0.30 (+0.26%)
Official Closing Price Updated: 4:15 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,257
Open 115.01
Bid (Size) 113.42 (2,600)
Ask (Size) 114.79 (2,600)
Prev. Close 114.11
Today's Range 114.19 - 115.14
52wk Range 90.60 - 118.00
Shares Outstanding N/A
Dividend Yield 1.26%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? ↗
October 11, 2026
VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research. 
Via The Motley Fool
Topics ETFs
News headline image
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP ↗
October 02, 2026
VanEck offers lower costs and double the dividend yield, while Invesco delivered stronger 1-year returns with more balanced holdings. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 3.0% below 52-week high
114.41
90.6052W Low 118.0052W High
1 Week 1.2% below 1-week high
108.661W Low 115.851W High

VanEck Pharmaceutical ETF (PPH) traded between $90.60 and $118.00 over the past 52 weeks and last traded at $114.41, 3.0% below its 52-week high. Over the past week it ranged between $108.66 and $115.85.

Past 12 Months
+3.5%
+3.5%
+4.1%
+11.3%
+10.3%
+24.2%
1W +$3.92
1M +$3.87
3M +$4.53
6M +$11.59
YTD +$10.69
1Y +$22.28

PPH was +24.2% over the past year, +11.3% over six months, +10.3% year to date, +3.5% in the last week.

12 Months vs Market
PPH
+24.2%
DIA
+12.2%
SPY
+14.7%
QQQ
+17.9%
IWM
+8.0%

Over the past 12 months PPH returned +24.2% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

Volume & Liquidity 0.67× 3-mo avg
Today 187,257 3-mo avg 280.5K
1W
431.1K
1M
339.7K
3M
280.5K
6M
260.2K
YTD
313.6K
1Y
341.4K

PPH most recently traded 187,257 shares against a 3-month average daily volume of 280.5K.

More News

Read More
News headline image
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? ↗
September 15, 2026
Via The Motley Fool
Topics ETFs
News headline image
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. ↗
September 11, 2026
Via The Motley Fool
Topics ETFs
News headline image
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus ↗
August 26, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗
August 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
PPH vs. IYH: Which Healthcare Fund Is the Better Buy? ↗
August 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
August 12, 2026
Via The Motley Fool
Topics ETFs
News headline image
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio? ↗
July 26, 2026
Via The Motley Fool
Topics ETFs
News headline image
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗
July 23, 2026
Via The Motley Fool
Topics ETFs
News headline image
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026? ↗
July 20, 2026
Via The Motley Fool
Topics ETFs
News headline image
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up? ↗
July 09, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? ↗
July 04, 2026
Via The Motley Fool
Topics ETFs
News headline image
Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? ↗
June 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. ↗
June 02, 2026
Via The Motley Fool
Topics ETFs
News headline image
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem ↗
May 27, 2026
Via The Motley Fool
Topics ETFs
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
March 10, 2026
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
March 09, 2026
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
FDA Vaccine Chief Vinay Prasad To Exit Agency In April: Report ↗
March 06, 2026
Via Stocktwits
News headline image
Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes ↗
February 25, 2026
Via Stocktwits
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
February 25, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report ↗
February 24, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China ↗
February 24, 2026
Via Stocktwits
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
February 23, 2026
Via Stocktwits
Topics Intellectual Property
News headline image
Why Is NVO Stock Falling Pre-Market Today? ↗
February 23, 2026
Via Stocktwits
Topics Government

Frequently Asked Questions

Is VanEck Pharmaceutical ETF publicly traded?
Yes, VanEck Pharmaceutical ETF is publicly traded.
What exchange does VanEck Pharmaceutical ETF trade on?
VanEck Pharmaceutical ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Pharmaceutical ETF?
The ticker symbol for VanEck Pharmaceutical ETF is PPH on the Nasdaq Stock Market
What is the current price of VanEck Pharmaceutical ETF?
The current price of VanEck Pharmaceutical ETF is 114.41
When was VanEck Pharmaceutical ETF last traded?
The last trade of VanEck Pharmaceutical ETF was at 10/16/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap